Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Cash flows from (used in) operations before changes in working capital |
10,324
EUR
|
6,405
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
5,868
EUR
|
1,950
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
6,523
EUR
|
1,279
EUR
|
| Adjustments for decrease (increase) in loans and advances | — | — |
| Adjustments for decrease (increase) in loans and advances to customers |
94,000
EUR
|
737,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
556,000
EUR
|
489,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
-
EUR
|
-
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, loans and advances |
57,000
EUR
|
225,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Repayments of bonds, notes and debentures |
166,000
EUR
|
246,000
EUR
|